PURE Bioscience, Inc.
PURE
$0.0653
$0.00538.83%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.95% | 10.78% | 15.43% | 12.88% | 9.91% |
| Total Depreciation and Amortization | -39.52% | -10.48% | 26.50% | -18.30% | -27.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.69% | -62.48% | -59.29% | -27.38% | -27.60% |
| Change in Net Operating Assets | 203.83% | 270.21% | 471.03% | 316.67% | 535.71% |
| Cash from Operations | 17.46% | 7.88% | 22.79% | 14.50% | 11.33% |
| Capital Expenditure | -- | -- | -- | 146.24% | 106.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 146.24% | 106.15% |
| Total Debt Issued | 5.56% | -16.67% | 75.86% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.56% | -16.67% | 75.86% | -34.29% | -48.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.75% | -8.10% | 67.51% | -225.56% | -362.15% |